Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation

被引：3
|
作者：
Wood, Brian R. [1 ]
Kassaye, Seble G. [2 ]
Gerstoft, Jan [3 ]
机构：
[1] Univ Washington, Div Allergy & Infect Dis, Seattle, WA USA
[2] Georgetown Univ, Dept Med, Washington, DC USA
[3] Univ Copenhagen, Dept Infect Dis, Rigshosp, Copenhagen, Denmark
来源：
AIDS | 2023年 / 37卷 / 04期
关键词：
RILPIVIRINE; FAILURE;
D O I：
10.1097/QAD.0000000000003476
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：689 / 691
页数：3
相关论文
共 50 条
  • [31] CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING ANTIRETROVIRAL THERAPY ADMINISTERED EVERY 2-MONTHS IS COST EFFECTIVE FOR THE TREATMENT OF HIV-1 IN SPAIN
    Moreno Guillen, S.
    Rivero, A.
    Ventayol, P.
    Falco, V.
    Torralba, M.
    Schroeder, M.
    Neches, V.
    Vallejo-Aparicio, L. A.
    Mackenzie, I.
    Turner, M.
    Harrison, C.
    VALUE IN HEALTH, 2022, 25 (12) : S122 - S122
  • [32] Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
    Christopoulos, Katerina A.
    Hickey, Matthew D.
    Rana, Aadia
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 11 - 18
  • [33] Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
    Moreno, Santiago
    Rivero, Antonio
    Ventayol, Pere
    Falco, Vicenc
    Torralba, Miguel
    Schroeder, Melanie
    Neches, Victoria
    Vallejo-Aparicio, Laura Amanda
    Mackenzie, Isaac
    Turner, Matthew
    Harrison, Cale
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (08) : 2039 - 2055
  • [34] Cabotegravir and rilpivirine concentrations and HIV-1 RNA suppression in male and female genital fluids and rectal tissue in people with HIV on antiretroviral therapy with long-acting intramuscular cabotegravir plus rilpivirine
    Fernandez, Analuz
    Scevola, Sofia
    Niubo, Jordi
    Sykes, Craig
    Schauer, Amanda P.
    Piatti, Camila
    Morenilla, Sandra
    Sedo, Alicia
    Soriano, Irene
    Garcia, Benito
    Medina, Daniel
    Tiraboschi, Juan
    Saumoy, Maria
    Cottrell, Mackenzie L.
    Imaz, Arkaitz
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 3 - 4
  • [35] Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
    Santiago Moreno
    Antonio Rivero
    Pere Ventayol
    Vicenç Falcó
    Miguel Torralba
    Melanie Schroeder
    Victoria Neches
    Laura Amanda Vallejo-Aparicio
    Isaac Mackenzie
    Matthew Turner
    Cale Harrison
    Infectious Diseases and Therapy, 2023, 12 : 2039 - 2055
  • [36] Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures
    Thoueille, Paul
    Cavassini, Matthias
    Guidi, Monia
    Buclin, Thierry
    Girardin, Francois R.
    Decosterd, Laurent A.
    Marzolini, Catia
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [37] The use and utility of toolkits in supporting cabotegravir plus rilpivirine long-acting implementation in the CARISEL (Cabotegravir And Rilpivirine Implementation Study in European Locations) study
    Trehan, Rekha
    Gutner, Cassidy
    Okoli, Chinyere
    Ghosn, Jade
    Vera, Francisco
    Florence, Eric
    Lutz, Thomas
    van der Valk, Marc
    Czarnogorski, Maggie
    HIV MEDICINE, 2023, 24 : 93 - 93
  • [38] Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study
    Gutner, Cassidy A.
    van der Valk, Marc
    Portilla, Joaquin
    Jeanmaire, Eliette
    Belkhir, Leila
    Lutz, Thomas
    Demoor, Rebecca
    Trehan, Rekha
    Scherzer, Jenny
    Pascual-Bernaldez, Miguel
    Ait-Khaled, Mounir
    Hernandez, Beatriz
    de Ruiter, Annemiek
    Anand, Savita Bakhshi
    Low, Emma L.
    Hadi, Monica
    Barnes, Nicola
    Sevdalis, Nick
    Mohammed, Perry
    Czarnogorski, Maggie
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23
  • [39] Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy
    D'Amico, Ronald
    Gomis, Santiago Cenoz
    Moodley, Riya
    Van Solingen-Ristea, Rodica
    Baugh, Bryan
    Van Landuyt, Erika
    Van Eygen, Veerle
    Min, Sherene
    Cutrell, Amy
    Foster, Caroline
    Chilton, Daniella
    Allard, Sabine D.
    Ruiter, Annemiek
    HIV MEDICINE, 2023, 24 (02) : 202 - 211
  • [40] Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations
    Gutner, Cassidy A.
    Hocqueloux, Laurent
    Jonsson-Oldenbuettel, Celia
    Vandekerckhove, Linos
    van Welzen, Berend J.
    Slama, Laurence
    Crusells-Canales, Maria
    Sierra, Julian Olalla
    DeMoor, Rebecca
    Scherzer, Jenny
    Ait-Khaled, Mounir
    Bontempo, Gilda
    Gill, Martin
    Patel, Natasha
    D'Amico, Ronald
    Hove, Kai
    Baugh, Bryan
    Barnes, Nicola
    Hadi, Monica
    Low, Emma L.
    Anand, Savita Bakhshi
    Hamilton, Alison
    Garges, Harmony P.
    Czarnogorski, Maggie
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 (07)
12345